迈瑞医疗
(300760)
| 流通市值：3297.96亿 | | | 总市值：3297.96亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 29,484,805,493 | 20,530,596,799 | 9,372,811,209 | 34,931,900,884 |
| 营业收入 | 29,484,805,493 | 20,530,596,799 | 9,372,811,209 | 34,931,900,884 |
| 二、营业总成本 | 17,867,270,338 | 12,390,670,510 | 6,073,471,557 | 21,991,204,875 |
| 营业成本 | 10,358,523,254 | 6,928,401,101 | 3,190,131,192 | 11,820,708,329 |
| 税金及附加 | 314,817,220 | 222,224,136 | 100,808,593 | 366,077,263 |
| 销售费用 | 3,664,616,797 | 2,934,958,832 | 1,485,484,939 | 5,702,924,130 |
| 管理费用 | 1,119,339,140 | 822,534,756 | 473,351,126 | 1,523,748,134 |
| 研发费用 | 2,592,345,180 | 1,775,300,575 | 947,431,880 | 3,432,658,732 |
| 财务费用 | -182,371,253 | -292,748,890 | -123,736,173 | -854,911,713 |
| 其中:利息费用 | 14,197,335 | 9,131,150 | 4,465,076 | 12,996,889 |
| 其中:利息收入 | 434,205,071 | 316,357,754 | 189,758,820 | 821,643,445 |
| 加:公允价值变动收益 | 126,883,062 | 126,284,421 | 126,027,777 | 79,401,838 |
| 加:投资收益 | 64,217,177 | 63,439,016 | -3,098,705 | -9,840,894 |
| 资产处置收益 | 7,932,009 | 3,540,498 | -316,183 | 2,464,577 |
| 资产减值损失(新) | -161,030,640 | -91,139,728 | -43,448,954 | -529,505,736 |
| 信用减值损失(新) | -188,199,618 | -134,331,607 | -66,413,250 | -244,194,525 |
| 其他收益 | 627,999,117 | 472,471,520 | 260,188,187 | 830,836,564 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 12,095,336,262 | 8,580,190,409 | 3,572,278,524 | 13,069,857,833 |
| 加:营业外收入 | 29,481,764 | 15,563,017 | 7,474,965 | 56,347,903 |
| 减:营业外支出 | 74,231,237 | 54,207,797 | 22,038,680 | 115,275,709 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 12,050,586,789 | 8,541,545,629 | 3,557,714,809 | 13,010,930,027 |
| 减:所得税费用 | 1,347,936,867 | 965,607,097 | 395,924,083 | 1,432,516,623 |
| 六、净利润 | 10,702,649,922 | 7,575,938,532 | 3,161,790,726 | 11,578,413,404 |
| 持续经营净利润 | 10,702,649,922 | 7,575,938,532 | 3,161,790,726 | 11,578,413,404 |
| 归属于母公司股东的净利润 | 10,637,075,305 | 7,560,737,744 | 3,159,898,674 | 11,582,226,085 |
| 少数股东损益 | 65,574,617 | 15,200,788 | 1,892,052 | -3,812,681 |
| (一)基本每股收益 | 8.78 | 6.24 | 2.61 | 9.56 |
| (二)稀释每股收益 | 8.78 | 6.24 | 2.61 | 9.56 |
| 八、其他综合收益 | -69,484,064 | -135,274,601 | -116,262,405 | 272,830,698 |
| 归属于母公司股东的其他综合收益 | -73,077,881 | -133,056,042 | -109,942,296 | 271,645,344 |
| 九、综合收益总额 | 10,633,165,858 | 7,440,663,931 | 3,045,528,321 | 11,851,244,102 |
| 归属于母公司股东的综合收益总额 | 10,563,997,424 | 7,427,681,702 | 3,049,956,378 | 11,853,871,429 |
| 归属于少数股东的综合收益总额 | 69,168,434 | 12,982,229 | -4,428,057 | -2,627,327 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |